Australian Clinical Labs Limited

ASX:ACL Voorraadrapport

Marktkapitalisatie: AU$692.4m

Australian Clinical Labs Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Australian Clinical Labs heeft een totaal eigen vermogen van A$177.8M en een totale schuld van A$55.1M, wat de schuld-eigenvermogensverhouding op 31% brengt. De totale activa en totale passiva bedragen respectievelijk A$593.1M en A$415.3M. De EBIT Australian Clinical Labs is A$62.6M waardoor de rentedekking 3.8 is. Het heeft contanten en kortetermijnbeleggingen van A$26.8M.

Belangrijke informatie

31.0%

Verhouding schuld/eigen vermogen

AU$55.06m

Schuld

Rente dekkingsratio3.8x
ContantAU$26.85m
AandelenAU$177.77m
Totaal verplichtingenAU$415.30m
Totaal activaAU$593.06m

Recente financiële gezondheidsupdates

Recent updates

Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Sep 03
Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

Sep 02
Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$133.6M ) van ACL } dekken niet de korte termijn passiva ( A$207.7M ).

Langlopende schulden: De kortetermijnactiva van ACL ( A$133.6M ) dekken de langetermijnschulden ( A$207.6M ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 15.9% ) ACL wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van ACL is de afgelopen 5 jaar gedaald van 204.2% naar 31%.

Schuldendekking: De schuld van ACL wordt goed gedekt door de operationele kasstroom ( 289.8% ).

Rentedekking: De rentebetalingen op de schuld van ACL worden goed gedekt door EBIT ( 3.8 x dekking).


Balans


Ontdek gezonde bedrijven